Eric H. Bernicker, MD

  • Houston Methodist thoracic medical oncologist
  • Director of medical thoracic oncology, Houston Methodist Cancer Center
  • Associate Professor of Clinical Medicine, Weill Cornell Medical College

Eric H. Bernicker, MD

Areas of Expertise

  • Cancer clinical trials
  • Eye cancers
  • Head/neck cancers
  • Immunotherapies and other targeted therapeutics
  • Lung cancer (non-small cell and small cell)
  • Mesothelioma

Credentials

BOARD CERTIFICATION
Medical Oncology | American Board of Internal Medicine
MEDICAL SCHOOL
Baylor College of Medicine - Houston, TX | 1990
RESIDENCY
Baylor College of Medicine - Houston, TX | 1994
FELLOWSHIP
Hematology | Baylor College of Medicine - Houston, TX | 1995
Medical Oncology | MD Anderson Cancer Center - Houston, TX | 1996

Publications

Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma
Anand, K, Phung, TL, Bernicker, EH, Cagle, PT, Olsen, RJ & Thomas, JS 2020, , Clinical Lung Cancer, vol. 21, no. 5, pp. 437-442. https://doi.org/10.1016/j.cllc.2020.05.007

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
COVID-19 and Cancer Consortium 2020, , The Lancet, vol. 395, no. 10241, pp. 1907-1918. https://doi.org/10.1016/S0140-6736(20)31187-9

Cancer cachexia: A multifactoral disease that needs a multimodal approach
Stubbins, R, Bernicker, EH & Quigley, EM 2020, , Current opinion in gastroenterology, vol. 36, no. 2, pp. 141-146. https://doi.org/10.1097/MOG.0000000000000603

Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database
Messer, JA, Zuhour, RJ, Haque, W, Lewis, GD, Schefler, AC, Wong, A, Bernicker, EH, Chevez-Barrios, P, Michelle Quan, E, Farach, A, Butler, EB, Hatch, SS & Teh, BS 2020, , Journal of Contemporary Brachytherapy, vol. 12, no. 4, pp. 303-310. https://doi.org/10.5114/jcb.2020.98108

A matter of comprehensive informed consent: Short-term mortality rates with definitive treatment options in elderly stage i NSCLC
Dalwadi, SM, Savjani, RR, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 42, no. 11, pp. 851-855. https://doi.org/10.1097/COC.0000000000000606

Socioeconomic Factors Associated with Lack of Treatment in Early Stage Non-Small Cell Lung Cancer
Dalwadi, SM, Zhang, J, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, Cancer Investigation, vol. 37, no. 9, pp. 506-511. https://doi.org/10.1080/07357907.2019.1666136


Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century
Dalwadi, SM, Lewis, GD, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, , Clinical Lung Cancer, vol. 20, no. 3, pp. 194-200. https://doi.org/10.1016/j.cllc.2018.11.004

Update on emerging biomarkers in lung cancer
Bernicker, EH, Allen, TC & Cagle, PT 2019, , Journal of Thoracic Disease, vol. 11, pp. S81-S88. https://doi.org/10.21037/jtd.2019.01.46

What the oncologist needs from the pathologist for tyrosine kinase inhibitor therapies
Bernicker, EH 2019, , Archives of Pathology and Laboratory Medicine, vol. 143, no. 9, pp. 1089-1092. https://doi.org/10.5858/arpa.2019-0210-SA

Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma
Schefler, AC, Koca, E, Bernicker, EH & Correa, ZM 2019, Graefes Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-019-04335-w

What the oncologist needs from the pathologist for immune therapies
Bernicker, EH 2019, , Archives of Pathology and Laboratory Medicine, vol. 143, no. 12, pp. 1513-1516. https://doi.org/10.5858/arpa.2019-0340-SA

Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ERþ/HER2 mutant breast cancer
Croessmann, S, Formisano, L, Kinch, LN, Gonzalez-Ericsson, PI, Sudhan, DR, Nagy, RJ, Mathew, A, Bernicker, EH, Cristofanilli, M, He, J, Cutler, RE, Lalani, AS, Miller, VA, Lanman, RB, Grishin, NV & Arteaga, CL 2019, , Clinical Cancer Research, vol. 25, no. 1, pp. 277-289. https://doi.org/10.1158/1078-0432.CCR-18-1544

Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors guideline from the college of American pathologists, the international association for the study of lung cancer, and the association for molecular pathology
Lindeman, NI, Cagle, PT, Aisner, DL, Arcila, ME, Beasley, MB, Bernicker, EH, Colasacco, C, Dacic, S, Hirsch, FR, Kerr, K, Kwiatkowski, DJ, Ladanyi, M, Nowak, JA, Sholl, L, Temple-Smolkin, R, Solomon, B, Souter, LH, Thunnissen, E, Tsao, MS, Ventura, CB, Wynes, MW & Yatabe, Y 2018, , Archives of Pathology and Laboratory Medicine, vol. 142, no. 3, pp. 321-346. https://doi.org/10.5858/arpa.2017-0388-CP

Correlation between programmed death receptor-1 expression in tumor-infiltrating lymphocytes and programmed death ligand-1 expression in non-small cell lung carcinoma
Monroig-Bosque, PDC, Driver, B, Morales-Rosado, JA, Deavers, M, Tacha, D, Bernicker, E, Cagle, PT & Miller, RA 2018, , Archives of Pathology and Laboratory Medicine, vol. 142, no. 11, pp. 1388-1393. https://doi.org/10.5858/arpa.2017-0516-OA


Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Lindeman, NI, Cagle, PT, Aisner, DL, Arcila, ME, Beasley, MB, Bernicker, E, Colasacco, C, Dacic, S, Hirsch, FR, Kerr, K, Kwiatkowski, DJ, Ladanyi, M, Nowak, JA, Sholl, L, Temple-Smolkin, R, Solomon, B, Souter, LH, Thunnissen, E, Tsao, MS, Ventura, CB, Wynes, MW & Yatabe, Y 2018, , Journal of Thoracic Oncology, vol. 13, no. 3, pp. 323-358. https://doi.org/10.1016/j.jtho.2017.12.001

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Lindeman, NI, Cagle, PT, Aisner, DL, Arcila, ME, Beasley, MB, Bernicker, E, Colasacco, C, Dacic, S, Hirsch, FR, Kerr, K, Kwiatkowski, DJ, Ladanyi, M, Nowak, JA, Sholl, L, Temple-Smolkin, R, Solomon, B, Souter, LH, Thunnissen, E, Tsao, MS, Ventura, CB, Wynes, MW & Yatabe, Y 2018, , Journal of Molecular Diagnostics, vol. 20, no. 2, pp. 129-159. https://doi.org/10.1016/j.jmoldx.2017.11.004

Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer
Schrock, AB, Welsh, A, Chung, JH, Pavlick, D, Bernicker, EH, Creelan, BC, Forcier, B, Ross, JS, Stephens, PJ, Ali, SM, Dagogo-Jack, I, Shaw, AT, Li, T, Ou, SHI & Miller, VA 2019, , Journal of Thoracic Oncology, vol. 14, no. 2, pp. 255-264. https://doi.org/10.1016/j.jtho.2018.10.008


Languages

  • English